 |
| |
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians. The Company's product, Testim, is a topical 1% testosterone once-a-day gel indicated for the treatment of hypogonadism. Hypogonadism is defined as reduced or absent secretion of testosterone which can lead to symptoms such as low energy, loss of libido, adverse changes in body composition, irritability and poor concentration. The product pipeline of the Company includes XIAFLEX (clostridial collagenase for injection) for the treatment of Dupuytren's contracture (Dupuytren's), XIAFLEX for the treatment of Peyronie's disease (Peyronie's), XIAFLEX for the treatment of Adhesive Capsulitis (frozen shoulder syndrome), AA4010, treatment for overactive bladder using the transmucosal film delivery system and fentanyl pain product using the transmucosal film delivery system.More from Reuters »
Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Auxilium Pharmaceuticals, Inc. (Auxilium) is a specialty biopharmaceutical company specializing on the development and marketing of pharmaceutical products. The company's products are marketed to urologists, endocrinologists, orthopedists and select primary care physicians. Testim is the product marketed by Auxilium. For the manufacturing of Testim, the company depends on contract manufacturers. The company's product pipeline consists of XIAFLEX, AA4010 and a pain device designed using its transmucosal film delivery system. Auxilium is headquartered in Pennsylvania, the U.S.
The Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile: http://www.companiesandmarkets.com/r.ashx?id=8E534Y8KL166531
|
—
